Drug
Selumetinib sulfate clinical trials
Also written AZD-6244 Hydrogen Sulfate, AZD6244 Hydrogen Sulphate and Koselugo.
Keep track of what changes. Save the selumetinib sulfate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Other names
Studies by the year they started
9 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2017 | 4 |
| 2020 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 9
Often tested with
Tested in the same studies.
AZD 6244 (3) · Olaparib (2) · Palbociclib (2) · Cediranib (1) · Ensartinib (1) · Erdafitinib (1) · Ivosidenib (1) · Larotrectinib (1)
Studies
Open first, then newest update. How each study uses selumetinib sulfate is read from its arms, and is right about nine times in ten.
Testing it · 9
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingPhase 2National Cancer Institute (NCI)NCT05564377Written as Selumetinib Sulfate
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruitingPhase 3National Cancer Institute (NCI)NCT04166409Written as Selumetinib Sulfate
- Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesActive, not recruitingPhase 1National Cancer Institute (NCI)NCT01364051Written as Selumetinib Sulfate
- A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT03871257Written as Selumetinib Sulfate
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Active, not recruitingPhase 2National Cancer Institute (NCI)NCT03155620Written as Selumetinib Sulfate
- Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)CompletedPhase 2National Cancer Institute (NCI)NCT03213691Written as Selumetinib Sulfate
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous NeurofibromaCompletedPhase 2National Cancer Institute (NCI)NCT02839720Written as Selumetinib Sulfate
- Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R MutationsCompletedPhase 2National Cancer Institute (NCI)NCT03040986Written as Selumetinib Sulfate
- Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerCompletedPhase 2National Cancer Institute (NCI)NCT00551070Written as Selumetinib Sulfate
Given in every arm · 2 — selumetinib sulfate is usual care beside what is tested
- Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialActive, not recruitingPhase 2National Cancer Institute (NCI)NCT05554328Written as Selumetinib Sulfate
- A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade GliomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT04576117Written as Selumetinib Sulfate
Codes
What other systems call selumetinib sulfate · ClinicalTrials.gg INT015565
- UNII (FDA) 807ME4B7IJSELUMETINIB SULFATEConfirmed FDA, Wikidata
- RxNorm 2361596One source FDA
- Wikidata Q27269126selumetinib sulfateConfirmed FDA, Wikidata
- NCI Thesaurus C95225Selumetinib SulfateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 807ME4B7IJ | SELUMETINIB SULFATE | Confirmed FDA, Wikidata |
| RxNorm | 2361596 | — | One source FDA |
| Wikidata | Q27269126 | selumetinib sulfate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C95225 | Selumetinib Sulfate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.